에 대한 최신 뉴스 Veeva Systems (NYSE:VEEV) 주식

Veeva Systems

Veeva Sys

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Large Cap

News

Movers

Trading Ideas

AFRM

AZPN

NTNX

PODD

TCOM

VEEV

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 어펌 홀딩스(NASDAQ:AFRM)의 주가는 강력한 4분기 실적과 낙관적인 1분기 가이던스에 따라 36.04% 상승했다. 몇몇 분석가는 주가 전망을 상향 조정했다.

어펌 및 몽고DB는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (8월 25일-8월 31일)

Veeva Systems Inc

VEEVA SYSTEMS ORD

Veeva Systems Announced The Expansion Of Veeva Vault QMS, Adding New Capabilities To Manage Medtech Field Actions And Product Recalls

Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) has outperformed the market over the past 10 years by 11.74% on an annualized basis producing an average annual return of 22.21%. Currently, Veeva Systems has a market capitalization of $35.63 billion. 
Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $7,278.37 today based on a price of $220.03 for VEEV at the time of writing.
<h3>Veeva Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726068615_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today

JP Morgan analyst Anne Samuel maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Neutral and raises the price target from $203 to $208.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Veeva Systems, Raises Price Target to $208

Truist Securities analyst Jailendra Singh maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Hold and raises the price target from $197 to $207.

Truist Securities Maintains Hold on Veeva Systems, Raises Price Target to $207

Veeva Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) short percent of float has risen 3.52% since its last report. The company recently reported that it has 2.17 million shares sold short, which is 1.47% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.28 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Veeva Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725306311_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Veeva Systems has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Veeva Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Veeva Systems's peer group average for short interest as a percentage of float is 6.46%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(VEEV) - Analyzing Veeva Systems's Short Interest

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) shares escalated 36.04% following strong&nbsp;fourth-quarter&nbsp;earnings and <a href="https://www.benzinga.com//node/40613433" target="_blank" rel="noreferrer noopener">upbeat&nbsp;first-quarter&nbsp;guidance</a>. Several analysts raised <a href="https://www.benzinga.com//node/40630056" target="_blank" rel="noreferrer noopener">the price forecasts on the stock</a>.</li>
<li>Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) stock jumped 18.80% after the company reported fourth-quarter&nbsp;financial results and issued&nbsp;first-quarter&nbsp;and FY25 <a href="https://www.benzinga.com//node/40614905" target="_blank" rel="noreferrer noopener">revenue&nbsp;guidance&nbsp;above estimates</a>. Many analysts <a href="https://www.benzinga.com//node/40626089" target="_blank" rel="noreferrer noopener">boosted the stock&#8217;s price target</a>.</li>
<li>Mongodb Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) stock gained 16.32% in the last week on better-than-expected Q2 financial results and issued strong guidance. Several analysts bumped <a href="https://www.benzinga.com/quote/MDB/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecasts on the stock</a>.</li>
<li>Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) stock increased 13.54% after it reported second-quarter results and raised its <a href="https://www.benzinga.com//node/40624075" target="_blank" rel="noreferrer noopener">FY25 earnings&nbsp;guidance</a>. Several analysts boosted their <a href="https://www.benzinga.com//node/40651188" target="_blank" rel="noreferrer noopener">forecasts on the stock</a>.</li>
<li>GE Vernova Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) upped 11.62% in the last week after William Blair initiated coverage on the stock <a href="https://www.benzinga.com/quote/GEV/analyst-ratings" target="_blank" rel="noreferrer noopener">with an Outperform rating</a>.</li>
<li>Trip.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) stock upped 11.42% after the company<a href="https://www.benzinga.com//node/40564652" target="_blank" rel="noreferrer noopener"> reported quarterly results</a>.</li>
<li>The Cooper Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) shares were up 11.30% after the company reported third-quarter results and issued&nbsp;above-estimates<a href="https://www.benzinga.com//node/40611992" target="_blank" rel="noreferrer noopener"> fourth-quarter&nbsp;and FY25&nbsp;guidance</a>.&nbsp;Several analysts<a href="https://www.benzinga.com/quote/COO/analyst-ratings" target="_blank" rel="noreferrer noopener"> upped the price target</a>.</li>
<li>Insulet Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) shares upped 9.94% after the company recently announced its Omnipod is now indicated for use by people <a href="https://www.benzinga.com//node/40562757" target="_blank" rel="noreferrer noopener">with type 2 diabetes in the US</a>.</li>
<li>Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) shares were up 8.44% after the company reported&nbsp;financial results and issued&nbsp;third-quarter&nbsp;and FY25 adjusted <a href="https://www.benzinga.com//node/40611557" target="_blank" rel="noreferrer noopener">EPS&nbsp;guidance&nbsp;above estimates</a>. Several analysts bumped the <a href="https://www.benzinga.com/quote/veev/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the company</a>.</li>
<li>Aspen Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZPN#NASDAQ">AZPN</a>) shares were up 8.12%.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/40675182/dollar-general-temu-parent-pdd-and-super-micro-computer-are-among-top-10-large-cap-losers-last-wee">Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Affirm

Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?

Whales with a lot of money to spend have taken a noticeably bearish stance on Veeva Systems.
Looking at options history for Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 0% of the investors opened trades with bullish expectations and 90% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $296,833 and 2, calls, for a total amount of $864,382.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $230.0 for Veeva Systems over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Veeva Systems's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Veeva Systems's whale trades within a strike price range from $100.0 to $230.0 in the last 30 days. 
<h3>Veeva Systems 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725046326_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VEEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$120.4</td>
<td>$117.2</td>
<td>$117.93</td>
<td>$100.00</td>
<td>$838.5K</td>
<td style="text-align: right;">90</td>
<td style="text-align: right;">71</td>
</tr>
<tr>
<td>VEEV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$6.4</td>
<td>$6.0</td>
<td>$6.4</td>
<td>$200.00</td>
<td>$77.4K</td>
<td style="text-align: right;">107</td>
<td style="text-align: right;">221</td>
</tr>
<tr>
<td>VEEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$13.3</td>
<td>$12.9</td>
<td>$13.2</td>
<td>$210.00</td>
<td>$39.6K</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">135</td>
</tr>
<tr>
<td>VEEV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$13.2</td>
<td>$13.0</td>
<td>$13.2</td>
<td>$210.00</td>
<td>$38.2K</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">135</td>
</tr>
<tr>
<td>VEEV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$13.2</td>
<td>$12.9</td>
<td>$13.2</td>
<td>$210.00</td>
<td>$31.6K</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">135</td>
</tr>
</tbody>
</table>

<h3>About Veeva Systems</h3>
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
In light of the recent options history for Veeva Systems, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Veeva Systems</h3>
<ul>
<li>With a volume of 602,776, the price of VEEV is up 0.14% at $217.33. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 96 days.</li>
</ul>
<h3>What The Experts Say On Veeva Systems</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $234.4.
<ul>
<li>In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $260. </li>
<li>An analyst from TD Cowen persists with their Hold rating on Veeva Systems, maintaining a target price of $192. </li>
<li>Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Veeva Systems with a target price of $230. </li>
<li>Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $250.</li>
<li>An analyst from B of A Securities has decided to maintain their Neutral rating on Veeva Systems, which currently sits at a price target of $240. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Veeva Systems options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Veeva Systems Unusual Options Activity For August 30

Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) has outperformed the market over the past 10 years by 11.02% on an annualized basis producing an average annual return of 21.88%. Currently, Veeva Systems has a market capitalization of $35.27 billion. 
Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 10 years ago, it would be worth $756.26 today based on a price of $218.18 for VEEV at the time of writing.
<h3>Veeva Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725026589_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday.
Shares of Build-A-Bear Workshop, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) rose sharply during Thursday&#8217;s session following better-than-expected <a href="https://www.benzinga.com/news/earnings/24/08/40624005/build-a-bear-workshops-q2-earnings-beat-sees-strong-improvement-in-q3-ytd-web-demand">second-quarter financial results.</a>
Build-A-Bear reported second-quarter revenue growth of 2.4% Y/Y to $111.8 million, beating the analyst consensus of $108.5 million. EPS of 64 cents (+12.3% Y/Y), beating the Wall Street view of 57 cents.
Build-A-Bear shares jumped 19.7% to $33.37 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) shares jumped 33.2% to $42.06 following strong fourth-quarter earnings and upbeat first-quarter guidance.</li>
<li>Eos Energy Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) gained 22.2% to $2.6750 after the company announced it achieved first performance milestones related to Carberus Capital Management&#8217;s investment, allowing the company to draw an additional $30 million from the delayed draw term loan.</li>
<li>Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) gained 20.9% to $63.22 after the company reported better-than-expected fourth-quarter financial results and issued FY25 revenue guidance above estimates.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELYM#NASDAQ">ELYM</a>) jumped 20.1% to $7.45.</li>
<li>Iris Energy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) gained 19.6% to $8.89 after the company announced a year-over-year increase in FY24 Bitcoin mining revenue.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) rose 15.7% to $1.0950 after the company reported a quarter-over-quarter increase in second-quarter deliveries.</li>
<li>Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) gained 14.5% to $100.49 after the company reported better-than-expected quarterly financial results raised its FY25 earnings guidance.</li>
<li>iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) rose 13.2% to $77.59. iRhythm Technologies expanded global reach with the launch of Zio&#xAE; Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain.</li>
<li>Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) gained 12% to $48.75.</li>
<li>The Cooper Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COO#NYSE">COO</a>) rose 11.1% to $105.00 after the company reported better-than-expected third-quarter financial results and issued FY25 guidance above estimates. Also, Baird and Wells Fargo raised their respective price targets on the stock.</li>
<li>Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) gained 10.1% to $12.06 after the company announced it authorized an additional repurchase of $150 million of its shares in conjunction with its existing $200 million buyback.</li>
<li>Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) climbed 8.8% to $216.85 after the company reported better-than-expected second-quarter financial results and issued FY25 adjusted EPS guidance above estimates.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) rose 8.5% to $21.62. The company issued a notice to terminate its $250 million credit facility.</li>
<li>Stevanato Group S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) gained 8.3% to $21.94.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) rose 6.5% to $18.97 after B of A maintained a Buy rating on the stock and raised its price target from $30 to $31.</li>
<li>Canadian Imperial Bank of Commerce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CM#NYSE">CM</a>) gained 6% to $57.81 after the company reported better-than-expected quarterly financial results.</li>
<li>West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) rose 6% to $315.43.</li>
<li>Nokia Oyj (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) gained 5.8% to $4.4350 following a report suggesting that Samsung has an interest in the company&#8217;s mobile networks assets.</li>
<li>NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) gained 5.7% to $3.9127.</li>
<li>Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) gained 5.6% to $132.39.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/08/40624754/top-2-materials-stocks-that-are-ticking-portfolio-bombs">Top 2 Materials Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Intraday Update

ALAB

ELYM

EOSE

IREN

IRTC

PSNY

STVN

Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday

TD Cowen analyst Charles Rhyee maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Hold and raises the price target from $180 to $192.

TD Cowen Maintains Hold on Veeva Systems, Raises Price Target to $192

Citigroup analyst Tyler Radke maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Buy and raises the price target from $273 to $281.

Citigroup Maintains Buy on Veeva Systems, Raises Price Target to $281

RBC Capital analyst Rishi Jaluria reiterates Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Outperform and maintains $250 price target.

Reiteration

RBC Capital Reiterates Outperform on Veeva Systems, Maintains $250 Price Target

Raymond James analyst Brian Peterson maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Outperform and raises the price target from $230 to $235.

Raymond James Maintains Outperform on Veeva Systems, Raises Price Target to $235

Barclays analyst Saket Kalia maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Overweight and raises the price target from $220 to $240.

Barclays Maintains Overweight on Veeva Systems, Raises Price Target to $240

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li>B of A Securities cut the price target for PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) from $133 to $130. B of A Securities analyst Heather Balsky maintained a Buy rating. PVH shares fell 6.4% to close at $97.75 on Wednesday. <a href="https://www.benzinga.com/quote/PVH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Rosenblatt lowered the price target for CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from $330 to $325. Rosenblatt analyst Catharine Trebnick maintained a Buy rating. CrowdStrike shares fell 2.1% to close at $264.20 on Wednesday. <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Loop Capital raised Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) price target from $240 to $270. Loop Capital analyst Yun Kim maintained a Hold rating. Salesforce shares fell 2% to close at $258.90 on Wednesday. <a href="https://www.benzinga.com/quote/CRM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird boosted the price target for Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) from $245 to $251. Baird analyst Joe Vruwink maintained an Outperform rating. Veeva shares fell 0.5% to close at $199.35 on Wednesday. <a href="https://www.benzinga.com/quote/VEEV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo raised NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) price target from $155 to $165. Wells Fargo analyst Aaron Rakers maintained an Overweight rating. NVIDIA shares fell 2.1% to close at $125.61 on Wednesday. <a href="https://www.benzinga.com/quote/NVDA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Williams Trading raised Shoe Carnival, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) price target from $42 to $51. Williams Trading analyst Sam Poser maintained a Buy rating. Shoe Carnival shares fell 6.1% to close at $40.47 on Wednesday.<a href="https://www.benzinga.com/quote/SCVL/analyst-ratings"> See how other analysts view this stock.</a></li>
<li>Evercore ISI Group increased the price target for Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) from $420 to $460. Evercore ISI Group analyst Mark Mahaney maintained an Outperform rating. Spotify shares fell 0.6% to close at $337.56 on Wednesday. <a href="https://www.benzinga.com/quote/SPOT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley cut Equinor ASA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) price target from $30.5 to $25.8. Morgan Stanley analyst Martijn Rats downgraded the stock from Equal-Weight to Underweight. Equinor shares closed at $27.10 on Wednesday. <a href="https://www.benzinga.com/quote/EQNR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler boosted Neurocrine Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) price target from $131 to $159. Piper Sandler analyst David Amsellem upgraded the stock from Neutral to Overweight. Neurocrine Biosciences shares fell 18.9% to close at $123.76 on Wednesday. <a href="https://www.benzinga.com/quote/NBIX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS raised HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) price target from $34 to $37. UBS analyst David Vogt maintained a Neutral rating. HP shares fell 2.4% to close at $34.76 on Wednesday. <a href="https://www.benzinga.com/quote/HPQ/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NVDA stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="519" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29084447/image-297-1024x519.png" alt="" class="wp-image-520687" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29084447/image-297-1024x519.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29084447/image-297-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29084447/image-297-768x390.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29084447/image-297.png 1301w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/08/40613611/jim-cramer-says-rtx-is-his-favorite-defense-stock-likes-this-semiconductor-stock-that-has-come-down">Jim Cramer Says RTX Is His Favorite Defense Stock, Likes This Semiconductor Stock That &#8216;Has Come Down A Great Deal&#8217;</a></li>
</ul>

Pre-Market Outlook

CRWD

EQNR

NBIX

NVDA

SCVL

SPOT

NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday

B of A Securities analyst Brad Sills maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Neutral and raises the price target from $204 to $240.

B of A Securities Maintains Neutral on Veeva Systems, Raises Price Target to $240

Baird analyst Joe Vruwink maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Outperform and raises the price target from $245 to $251.

Baird Maintains Outperform on Veeva Systems, Raises Price Target to $251

WIIM

Veeva Systems shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 and FY25 adjusted EPS guidance above estimates.

Needham analyst Ryan MacDonald reiterates Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Buy and maintains $260 price target.

Needham Reiterates Buy on Veeva Systems, Maintains $260 Price Target

Piper Sandler analyst Brent Bracelin maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Overweight and raises the price target from $225 to $230.

Piper Sandler Maintains Overweight on Veeva Systems, Raises Price Target to $230

Fidelity Select Health Care Portfolio Q2 2024 Review

Veeva Systems recently announced its quarterly results that continued to impress the market. Vault CRM continues to remain the buzz word for Veeva as Salesforce gears up for more direct competition with it.

Cloud Stocks: Salesforce Preps To Enter Veeva's Territory

Veeva Systems (VEEV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Craig Hettenbach from ...

Analyst Issues Sell Rating for Veeva Systems Ahead of Dreamforce Conference Amid Market Volatility Concerns

Veeva Systems ( ($VEEV) ) has shared an update. Veeva Systems Inc. has announced the appointment of Brian Van Wagener as their new Chief Financial ...

Veeva Systems Welcomes Brian Van Wagener as New CFO

IHF: Healthcare Dashboard For September

Oppenheimer analyst Kenneth Wong maintained a Buy rating on Veeva Systems (VEEV – Research Report) today and set a price target of $230.00. The com...

Oppenheimer Sticks to Their Buy Rating for Veeva Systems (VEEV)

Veeva Systems: SMB Sector Is Growing Momentum

In a report released today, Kenneth Wong from Oppenheimer maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of...

Oppenheimer Keeps Their Buy Rating on Veeva Systems (VEEV)

Analyst Craig Hettenbach of Morgan Stanley maintained a Sell rating on Veeva Systems (VEEV – Research Report), retaining the price target of $173.0...

Veeva Systems Sell Rating: Competitive and Regulatory Challenges Ahead

Veeva Systems faces increasing competition from Salesforce: Morgan Stanley

ALKS

ALNY

BMYMP

COLL

EXAS

EXEL

GEHC

GKOS

HRMY

INSP

INVA

NONOF

PRCT

REGN

Press Releases

Vita Global Sciences Partners with Veeva to Streamline Clinical Data Management

Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption

Veeva to Release Fiscal 2025 Second Quarter Results on August 28, 2024

Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit

Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control

New Service Center in Veeva Vault CRM Suite Unifies Sales and Service

Earnings

Veeva Announces Fiscal 2025 Second Quarter Results

Veeva to Present at Upcoming Investor Conference

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

Veeva Vault QMS Adds Field Actions and Recall Management for Medtech

American Well Corporation Class A Common Stock

American Well

Augmedix

CareCloud

Certara

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

MultiPlan Corporation Class A Common Stock

MultiPlan

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Sharecare

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Waystar Holding

JP Morgan

Truist Securities

TD Cowen

Citigroup

Piper Sandler

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 어펌 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>)의 주가는 강력한 4분기 실적과 낙관적인 <a href="https://www.benzinga.com//node/40613433" target="_blank" rel="noreferrer noopener">1분기 가이던스</a>에 따라 36.04% 상승했다. 몇몇 분석가는 <a href="https://www.benzinga.com//node/40630056" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정</a>했다.
2. 뉴타닉스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>)는 회사가 4분기 재무 결과를 보고하고 1분기 및 2025 회계연도 <a href="https://www.benzinga.com//node/40614905" target="_blank" rel="noreferrer noopener">매출 가이던스를 예상치</a>보다 높게 발표한 후 18.80% 상승했다. 많은 분석가들이 <a href="https://www.benzinga.com//node/40626089" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정</a>했다.
3. 몽고DB(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>)는 예상보다 나은 2분기 재무 결과와 강력한 지침을 발표하여 지난주 주가가 16.32% 상승했다. 몇몇 분석가들이 <a href="https://www.benzinga.com/quote/MDB/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정</a>했다.
4. 베스트 바이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>)가 2분기 실적을 보고하고 <a href="https://www.benzinga.com//node/40624075" target="_blank" rel="noreferrer noopener">2025 회계연도 실적 가이던스를 상향 조정</a>한 후 주가는 13.54% 상승했다. 몇몇 분석가들은 <a href="https://www.benzinga.com//node/40651188" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주식에 대한 전망을 높였다</a>.
5. GE 베르노바(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>)의 주식은 투자 은행 윌리엄 블레어(William Blair)가 주식을 <a href="https://www.benzinga.com/quote/GEV/analyst-ratings" target="_blank" rel="noreferrer noopener">아웃퍼폼 등급으로 커버리지를 개시</a>한 후 11.62% 상승했다.
6. 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/40564652" target="_blank" rel="noreferrer noopener">분기 실적을 발표</a>한 후 11.42% 상승했다.
7. 쿠퍼 컴퍼니스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>)의 주식은 3분기 실적을 발표하고 예상치를 상회하는 <a href="https://www.benzinga.com//node/40611992" target="_blank" rel="noreferrer noopener">4분기 및 2025 회계연도 가이던스를 발표</a>한 후 11.30% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/COO/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정</a>했다.
8. 인슐렛 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>)의 주식은 최근 자사의 패치형 웨어러블 인슐린 펌프인 옴니팟(Omnipod)이 <a href="https://www.benzinga.com//node/40562757" target="_blank" rel="noreferrer noopener">미국에서 제2형 당뇨병 환자</a>에게 사용하도록 지정되었다고 발표한 후 주가는 9.94% 상승했다.
9. 비바 시스템즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>)의 주식은 회사가 재무 실적을 발표하고 3분기 및 2025 회계연도 조정 <a href="https://www.benzinga.com//node/40611557" target="_blank" rel="noreferrer noopener">EPS 가이던스를 예상치 이상으로 발표</a>한 후 8.44% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/veev/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정</a>했다.
10. 아스펜 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZPN#NASDAQ">AZPN</a>)의 주식은 8.12% 상승했다.
다음 읽기:
<a href="https://kr.benzinga.com/news/usa/stocks/%eb%8b%ac%eb%9f%ac-%ec%a0%9c%eb%84%88%eb%9f%b4-%eb%b0%8f-%ed%85%8c%eb%ac%b4%ec%9d%98-%eb%aa%a8%ed%9a%8c%ec%82%ac-pdd%eb%8a%94-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ec%95%85%ec%9d%98-%ec%84%b1%ea%b3%bc/" target="_blank" rel="noopener">달러 제너럴 및 PDD는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (8월 25일-8월 31일)</a>
Affirm 제공
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Veeva Systems

뉴스

에 대한 최신 뉴스 Veeva Systems (NYSE:VEEV) 주식

화요일, 9월 03, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌